Skip to main content
Erschienen in: Reactions Weekly 1/2021

01.07.2021 | Case report

Gimeracil/oteracil/tegafur/ramucirumab

Lack of efficacy in stage III gastric cancer : case report

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Kidogami S, et al. [Two Cases of Advanced Gastric Cancer with Para-Aortic Lymph Node Metastasis or Recurrence for Which Nivolumab Therapy Were Effective]. Gan to Kagaku Ryoho 48: 575-577, No. 4, Apr 2021 [Japanese; summarised from a translation] Kidogami S, et al. [Two Cases of Advanced Gastric Cancer with Para-Aortic Lymph Node Metastasis or Recurrence for Which Nivolumab Therapy Were Effective]. Gan to Kagaku Ryoho 48: 575-577, No. 4, Apr 2021 [Japanese; summarised from a translation]
Metadaten
Titel
Gimeracil/oteracil/tegafur/ramucirumab
Lack of efficacy in stage III gastric cancer : case report
Publikationsdatum
01.07.2021
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-99100-9

Weitere Artikel der Ausgabe 1/2021

Reactions Weekly 1/2021 Zur Ausgabe

Case report

Erenumab

Case report

Risperidone